ARVIND KALYAN SUNDARAM

Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology NORMAL, IL NPI 1265780951

General Payments — all program years on this page

$3,375.10

  • Category: General Payments
  • Program years: PY2020–2024
  • Record count: 35
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,701.79 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $955.2915
Travel and Lodging $746.505

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Abbott Laboratories $1,488.1913
Acerta Pharma LLC $93.751
NOVARTIS PHARMACEUTICALS CORPORATION $68.323
SCPHARMACEUTICALS INC. $20.481
Esperion Therapeutics, Inc. $16.451
ABIOMED $14.601

By program year

Program yearAmountRecords
2020 $246.382
2021 $549.734
2022 $426.134
2023 $451.075
2024 $1,701.7920

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087142880 Novartis Pharmaceuticals Corporation $19.76 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087142884 Novartis Pharmaceuticals Corporation $22.85 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087142888 Novartis Pharmaceuticals Corporation $25.71 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105782984 AstraZeneca Pharmaceuticals LP $93.75 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124939380 Abbott Laboratories $150.61 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124939384 Abbott Laboratories $88.60 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124939388 Abbott Laboratories $65.04 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124939392 Abbott Laboratories $71.53 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124939395 Abbott Laboratories $192.04 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124939399 Abbott Laboratories $90.90 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124939403 Abbott Laboratories $62.97 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124939407 Abbott Laboratories $20.00 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125399080 Abbott Laboratories $140.00 02/08/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1125399082 Abbott Laboratories $231.74 02/08/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1125399084 Abbott Laboratories $231.74 02/08/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1125399086 Abbott Laboratories $134.00 03/07/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1125399088 Abbott Laboratories $9.02 02/08/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1129440734 Esperion Therapeutics, Inc. $16.45 08/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132306992 SCPHARMACEUTICALS INC. $20.48 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142270289 ABIOMED $14.60 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.